id
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
list | ner_tags
list |
|---|---|---|---|---|---|
NCT02873598
|
48:78:cancer
|
Histologically or cytopathologically confirmed adenocarcinoma of the pancreas
| 1
|
[
"Histologically",
"or",
"cytopathologically",
"confirmed",
"adenocarcinoma",
"of",
"the",
"pancreas"
] |
[
0,
0,
0,
0,
3,
3,
3,
3
] |
NCT02706249
|
21:42:chronic_disease
|
History of previous venous thromboembolic event (excluding superficial vein thrombosis)
| 1
|
[
"History",
"of",
"previous",
"venous",
"thromboembolic",
"event",
"(",
"excluding",
"superficial",
"vein",
"thrombosis",
")"
] |
[
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02553642
|
5:11:treatment,89:94:cancer,106:119:treatment
|
The biopsy site must, in the opinion of the investigator, be likely to yield acceptable tumor sample for core biopsies as described in Appendix 4
| 1
|
[
"The",
"biopsy",
"site",
"must",
",",
"in",
"the",
"opinion",
"of",
"the",
"investigator",
",",
"be",
"likely",
"to",
"yield",
"acceptable",
"tumor",
"sample",
"for",
"core",
"biopsies",
"as",
"described",
"in",
"Appendix",
"4"
] |
[
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT02466685
|
18:36:chronic_disease
|
Individuals with tardive dyskinesia
| 1
|
[
"Individuals",
"with",
"tardive",
"dyskinesia"
] |
[
0,
0,
2,
2
] |
NCT02313753
|
9:27:chronic_disease
|
Current psychotic symptoms severe enough to impair study participation
| 1
|
[
"Current",
"psychotic",
"symptoms",
"severe",
"enough",
"to",
"impair",
"study",
"participation"
] |
[
0,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02920086
|
,,,,,80:93:chronic_disease
|
Chronic obstructive lung disease - 2 of the 4 of: baseline PaCO2 of > 45 torr, cor pulmonale
| 1
|
[
"Chronic",
"obstructive",
"lung",
"disease",
"-",
"2",
"of",
"the",
"4",
"of",
":",
"baseline",
"PaCO2",
"of",
">",
"45",
"torr",
",",
"cor",
"pulmonale"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT02012296
|
,,38:50:treatment
|
PSA =<1.25 times the PSA at start of enzalutamide
| 1
|
[
"PSA",
"=",
"<",
"1.25",
"times",
"the",
"PSA",
"at",
"start",
"of",
"enzalutamide"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT03069469
|
1:23:chronic_disease
|
Malabsorption syndrome or other illness that could affect oral absorption
| 1
|
[
"Malabsorption",
"syndrome",
"or",
"other",
"illness",
"that",
"could",
"affect",
"oral",
"absorption"
] |
[
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02864862
|
41:44:allergy_name,46:56:allergy_name,58:67:allergy_name,69:78:allergy_name,80:91:allergy_name,96:106:allergy_name
|
allergy to antibiotics contained in the ADM (Gentimicin, Cefoxitin, Lincomcin, polymixin B and Vancomycin) will not be included in the immediate implant combined with ADM group
| 1
|
[
"allergy",
"to",
"antibiotics",
"contained",
"in",
"the",
"ADM",
"(",
"Gentimicin",
",",
"Cefoxitin",
",",
"Lincomcin",
",",
"polymixin",
"B",
"and",
"Vancomycin",
")",
"will",
"not",
"be",
"included",
"in",
"the",
"immediate",
"implant",
"combined",
"with",
"ADM",
"group"
] |
[
0,
0,
0,
0,
0,
0,
4,
0,
4,
0,
4,
0,
4,
0,
4,
4,
0,
4,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02310399
|
18:40:treatment
|
Involvement in a rehabilitation program that emphasizes development of auditory skills with or without the use of supplementary visual communication
| 1
|
[
"Involvement",
"in",
"a",
"rehabilitation",
"program",
"that",
"emphasizes",
"development",
"of",
"auditory",
"skills",
"with",
"or",
"without",
"the",
"use",
"of",
"supplementary",
"visual",
"communication"
] |
[
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02707471
|
45:72:chronic_disease
|
unable to provide meaningful consent (e.g., severe cognitive impairment)
| 1
|
[
"unable",
"to",
"provide",
"meaningful",
"consent",
"(",
"e.g.",
",",
"severe",
"cognitive",
"impairment",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0
] |
NCT02982226
|
25:45:chronic_disease
|
Evidence of significant neurological disease of either foot
| 1
|
[
"Evidence",
"of",
"significant",
"neurological",
"disease",
"of",
"either",
"foot"
] |
[
0,
0,
0,
2,
2,
0,
0,
0
] |
NCT02158234
|
,,,143:152:treatment
|
Women of childbearing potential or sexually active males must be willing to use effective contraception throughout their participation in the treatment phase of the study
| 1
|
[
"Women",
"of",
"childbearing",
"potential",
"or",
"sexually",
"active",
"males",
"must",
"be",
"willing",
"to",
"use",
"effective",
"contraception",
"throughout",
"their",
"participation",
"in",
"the",
"treatment",
"phase",
"of",
"the",
"study"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT02106598
|
40:57:treatment
|
Newly diagnosed patients with previous excisional biopsy
| 1
|
[
"Newly",
"diagnosed",
"patients",
"with",
"previous",
"excisional",
"biopsy"
] |
[
0,
0,
0,
0,
0,
1,
1
] |
NCT02376205
|
,19:33:treatment
|
More than 2-level ACDF surgeries
| 1
|
[
"More",
"than",
"2-level",
"ACDF",
"surgeries"
] |
[
0,
0,
0,
1,
1
] |
NCT02366819
|
,,,,,,,242:251:treatment
|
Women of child-bearing potential and men must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry and for the duration of study participation, up until 30 days after final study treatment
| 1
|
[
"Women",
"of",
"child-bearing",
"potential",
"and",
"men",
"must",
"agree",
"to",
"use",
"adequate",
"contraception",
"(",
"hormonal",
"or",
"barrier",
"method",
"of",
"birth",
"control",
";",
"abstinence",
")",
"prior",
"to",
"study",
"entry",
"and",
"for",
"the",
"duration",
"of",
"study",
"participation",
",",
"up",
"until",
"30",
"days",
"after",
"final",
"study",
"treatment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02251431
|
7:19:chronic_disease
|
Prior pancreatitis
| 1
|
[
"Prior",
"pancreatitis"
] |
[
0,
2
] |
NCT02006069
|
9:25:chronic_disease
|
Primary valvular disease
| 1
|
[
"Primary",
"valvular",
"disease"
] |
[
0,
2,
2
] |
NCT02496208
|
39:49:cancer
|
Histologically confirmed diagnosis of metastatic
| 1
|
[
"Histologically",
"confirmed",
"diagnosis",
"of",
"metastatic"
] |
[
0,
0,
0,
0,
3
] |
NCT01473628
|
21:24:chronic_disease
|
Patients with known HIV infection
| 1
|
[
"Patients",
"with",
"known",
"HIV",
"infection"
] |
[
0,
0,
0,
2,
0
] |
NCT01011777
|
57:81:chronic_disease
|
Renal ultrasound demonstrating Society of Fetal Urology Grade III hydronephrosis (widely split renal pelvis, renal calices uniformly dilated, no parenchymal thinning)
| 1
|
[
"Renal",
"ultrasound",
"demonstrating",
"Society",
"of",
"Fetal",
"Urology",
"Grade",
"III",
"hydronephrosis",
"(",
"widely",
"split",
"renal",
"pelvis",
",",
"renal",
"calices",
"uniformly",
"dilated",
",",
"no",
"parenchymal",
"thinning",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02578641
|
18:21:cancer,64:79:treatment,83:90:treatment
|
undifferentiated NPC* who do not have curative options such as chemo-radiation or surgery
| 1
|
[
"undifferentiated",
"NPC",
"*",
"who",
"do",
"not",
"have",
"curative",
"options",
"such",
"as",
"chemo-radiation",
"or",
"surgery"
] |
[
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1
] |
NCT02529644
|
,143:146:chronic_disease
|
Minors 18 and under are intentionally excluded since the intervention study has been designed specifically for adults with information of how HIV affects the African American adult population
| 1
|
[
"Minors",
"18",
"and",
"under",
"are",
"intentionally",
"excluded",
"since",
"the",
"intervention",
"study",
"has",
"been",
"designed",
"specifically",
"for",
"adults",
"with",
"information",
"of",
"how",
"HIV",
"affects",
"the",
"African",
"American",
"adult",
"population"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0
] |
NCT02204098
|
7:10:chronic_disease
|
Known HIV-positive status
| 1
|
[
"Known",
"HIV-positive",
"status"
] |
[
0,
2,
0
] |
NCT02942095
|
1:27:cancer
|
Non-small cell lung cancer
| 1
|
[
"Non-small",
"cell",
"lung",
"cancer"
] |
[
3,
3,
3,
3
] |
NCT02315196
|
7:20:treatment,40:46:treatment,55:65:cancer
|
Prior anthracycline, platinum salt, or taxane for any malignancy
| 1
|
[
"Prior",
"anthracycline",
",",
"platinum",
"salt",
",",
"or",
"taxane",
"for",
"any",
"malignancy"
] |
[
0,
1,
0,
0,
0,
0,
0,
1,
0,
0,
3
] |
NCT02608125
|
15:38:cancer
|
Patients with glioblastoma multiforme
| 1
|
[
"Patients",
"with",
"glioblastoma",
"multiforme"
] |
[
0,
0,
3,
3
] |
NCT02171429
|
22:46:chronic_disease,72:82:chronic_disease,104:120:chronic_disease,125:141:treatment
|
History of active or latent tuberculosis (TB), recurrent opportunistic infections, severe disseminated viral infections and organ transplant
| 1
|
[
"History",
"of",
"active",
"or",
"latent",
"tuberculosis",
"(",
"TB",
")",
",",
"recurrent",
"opportunistic",
"infections",
",",
"severe",
"disseminated",
"viral",
"infections",
"and",
"organ",
"transplant"
] |
[
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
2,
0,
0,
0,
2,
2,
0,
1,
1
] |
NCT02565901
|
17:35:cancer,48:72:treatment,76:100:treatment,94:100:treatment,119:149:cancer,151:157:cancer,159:164:cancer,168:175:cancer,179:190:cancer,194:210:cancer
|
The presence of metastatic disease amenable to computed tomography (CT) or ultrasound guided biopsy; this may include thoracolumbar vertebral bodies, pelvis, femur or humerus or soft tissue or nodal metastasis amenable to biopsy
| 1
|
[
"The",
"presence",
"of",
"metastatic",
"disease",
"amenable",
"to",
"computed",
"tomography",
"(",
"CT",
")",
"or",
"ultrasound",
"guided",
"biopsy",
";",
"this",
"may",
"include",
"thoracolumbar",
"vertebral",
"bodies",
",",
"pelvis",
",",
"femur",
"or",
"humerus",
"or",
"soft",
"tissue",
"or",
"nodal",
"metastasis",
"amenable",
"to",
"biopsy"
] |
[
0,
0,
0,
3,
3,
0,
0,
1,
1,
1,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
3,
3,
3,
0,
3,
0,
3,
0,
3,
0,
3,
3,
0,
3,
3,
0,
0,
0
] |
NCT03018704
|
12:20:chronic_disease
|
history of glaucoma
| 1
|
[
"history",
"of",
"glaucoma"
] |
[
0,
0,
2
] |
NCT02304458
|
42:62:chronic_disease
|
these patients will not be evaluable for hematologic toxicity
| 1
|
[
"these",
"patients",
"will",
"not",
"be",
"evaluable",
"for",
"hematologic",
"toxicity"
] |
[
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT00630565
|
46:56:treatment
|
Patients can also be deemed not eligible for transplant because of specific organ toxicity
| 1
|
[
"Patients",
"can",
"also",
"be",
"deemed",
"not",
"eligible",
"for",
"transplant",
"because",
"of",
"specific",
"organ",
"toxicity"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT00630565
|
17:38:treatment
|
patient refuses allogeneic transplant
| 1
|
[
"patient",
"refuses",
"allogeneic",
"transplant"
] |
[
0,
0,
1,
1
] |
NCT01967823
|
51:67:treatment,82:111:treatment,117:135:cancer
|
Patients must have previously received first-line standard therapy (or effective salvage chemotherapy regimens) for metastatic disease, if known to be effective for that disease, and have been either non-responders (progressive disease) or have recurred
| 1
|
[
"Patients",
"must",
"have",
"previously",
"received",
"first-line",
"standard",
"therapy",
"(",
"or",
"effective",
"salvage",
"chemotherapy",
"regimens",
")",
"for",
"metastatic",
"disease",
",",
"if",
"known",
"to",
"be",
"effective",
"for",
"that",
"disease",
",",
"and",
"have",
"been",
"either",
"non-responders",
"(",
"progressive",
"disease",
")",
"or",
"have",
"recurred"
] |
[
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
1,
1,
1,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02321501
|
,,,,,131:140:treatment,,,,
|
Sexually active males unless they use a condom during intercourse while taking drug and for 3 months after the last dose of study treatment. Male patients for 3 months should not father a child in this period. A condom is required to be used also by vasectomized men in order to prevent delivery of the drug via seminal fluid. Also male patients whose sexual partner(s) are WOCBP who are not willing to use adequate contraception during the study and for 3 months after the end of enrollment
| 1
|
[
"Sexually",
"active",
"males",
"unless",
"they",
"use",
"a",
"condom",
"during",
"intercourse",
"while",
"taking",
"drug",
"and",
"for",
"3",
"months",
"after",
"the",
"last",
"dose",
"of",
"study",
"treatment",
".",
"Male",
"patients",
"for",
"3",
"months",
"should",
"not",
"father",
"a",
"child",
"in",
"this",
"period",
".",
"A",
"condom",
"is",
"required",
"to",
"be",
"used",
"also",
"by",
"vasectomized",
"men",
"in",
"order",
"to",
"prevent",
"delivery",
"of",
"the",
"drug",
"via",
"seminal",
"fluid",
".",
"Also",
"male",
"patients",
"whose",
"sexual",
"partner",
"(",
"s",
")",
"are",
"WOCBP",
"who",
"are",
"not",
"willing",
"to",
"use",
"adequate",
"contraception",
"during",
"the",
"study",
"and",
"for",
"3",
"months",
"after",
"the",
"end",
"of",
"enrollment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02134392
|
1:7:chronic_disease,
|
Anemia on complete blood count
| 1
|
[
"Anemia",
"on",
"complete",
"blood",
"count"
] |
[
2,
0,
0,
0,
0
] |
NCT02181478
|
1:19:treatment,24:47:cancer,51:88:cancer
|
Concurrent therapy for extramedullary leukemia or central nervous system (CNS) lymphoma
| 1
|
[
"Concurrent",
"therapy",
"for",
"extramedullary",
"leukemia",
"or",
"central",
"nervous",
"system",
"(",
"CNS",
")",
"lymphoma"
] |
[
1,
1,
0,
3,
3,
0,
3,
3,
3,
3,
3,
0,
0
] |
NCT02332291
|
20:33:treatment
|
Current or planned psychotherapy
| 1
|
[
"Current",
"or",
"planned",
"psychotherapy"
] |
[
0,
0,
0,
1
] |
NCT02875301
|
15:39:chronic_disease
|
not including general anxiety disorder
| 1
|
[
"not",
"including",
"general",
"anxiety",
"disorder"
] |
[
0,
0,
2,
2,
2
] |
NCT02321501
|
,,,,,,,,,,,,,,,371:387:cancer
|
Absolute Neutrophil Count (ANC) >/= 1,500/microliter; Platelets >/= 100,000/microliter; Hemoglobin (Hgb) >/= 9 g/dL; Creatinine </= 1.5 X upper limit of normal (ULN); Prothrombin Time (PT), Partial Thromboplastin Time(PTT) </= 1.5 X ULN; Total bilirubin </= 1.5X ULN; Alanine Transaminase (ALT) and Aspartate Aminotransferase (AST) < 1.5 X ULN (< 5 X ULN if patient has liver metastasis)
| 1
|
[
"Absolute",
"Neutrophil",
"Count",
"(",
"ANC",
")",
">",
"/=",
"1,500/microliter",
";",
"Platelets",
">",
"/=",
"100,000/microliter",
";",
"Hemoglobin",
"(",
"Hgb",
")",
">",
"/=",
"9",
"g/dL",
";",
"Creatinine",
"<",
"/=",
"1.5",
"X",
"upper",
"limit",
"of",
"normal",
"(",
"ULN",
")",
";",
"Prothrombin",
"Time",
"(",
"PT",
")",
",",
"Partial",
"Thromboplastin",
"Time",
"(",
"PTT",
")",
"<",
"/=",
"1.5",
"X",
"ULN",
";",
"Total",
"bilirubin",
"<",
"/=",
"1.5X",
"ULN",
";",
"Alanine",
"Transaminase",
"(",
"ALT",
")",
"and",
"Aspartate",
"Aminotransferase",
"(",
"AST",
")",
"<",
"1.5",
"X",
"ULN",
"(",
"<",
"5",
"X",
"ULN",
"if",
"patient",
"has",
"liver",
"metastasis",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0
] |
NCT01532687
|
24:81:treatment
|
Measurable disease per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1
| 1
|
[
"Measurable",
"disease",
"per",
"Response",
"Evaluation",
"Criteria",
"in",
"Solid",
"Tumors",
"(",
"RECIST",
")",
"1.1"
] |
[
0,
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
0,
0
] |
NCT02332863
|
1:4:treatment
|
EUS evidence of vessel interfering with path of fiducial marker
| 1
|
[
"EUS",
"evidence",
"of",
"vessel",
"interfering",
"with",
"path",
"of",
"fiducial",
"marker"
] |
[
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02258438
|
1:21:chronic_disease
|
type 1 or 2 diabetes
| 1
|
[
"type",
"1",
"or",
"2",
"diabetes"
] |
[
2,
2,
2,
2,
2
] |
NCT02304458
|
21:55:chronic_disease,59:70:chronic_disease,74:75:chronic_disease
|
Patients with known human immunodeficiency virus (HIV) or hepatitis B or C
| 1
|
[
"Patients",
"with",
"known",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
"or",
"hepatitis",
"B",
"or",
"C"
] |
[
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
2,
2,
0,
2
] |
NCT02056873
|
41:50:treatment
|
(If the subject chooses not to have the treatment, they cannot participate in the study
| 1
|
[
"(",
"If",
"the",
"subject",
"chooses",
"not",
"to",
"have",
"the",
"treatment",
",",
"they",
"can",
"not",
"participate",
"in",
"the",
"study"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01494324
|
1:15:treatment,
|
Platelet count of <50,000 that cannot be corrected with transfusion
| 1
|
[
"Platelet",
"count",
"of",
"<",
"50,000",
"that",
"can",
"not",
"be",
"corrected",
"with",
"transfusion"
] |
[
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01968590
|
1:48:cancer
|
malignant peripheral nerve sheath tumor (MPNST)
| 1
|
[
"malignant",
"peripheral",
"nerve",
"sheath",
"tumor",
"(",
"MPNST",
")"
] |
[
3,
3,
3,
3,
3,
3,
0,
0
] |
NCT03141164
|
1:19:chronic_disease
|
visual impairments due to partial vision loss
| 1
|
[
"visual",
"impairments",
"due",
"to",
"partial",
"vision",
"loss"
] |
[
2,
2,
0,
0,
0,
0,
0
] |
NCT02576444
|
66:81:chronic_disease,89:105:chronic_disease,145:163:treatment
|
Patients with known (testing is not part of the protocol) active hepatic disease (i.e., Hepatitis B or C) due to risk of drug interactions with anti-viral therapy
| 1
|
[
"Patients",
"with",
"known",
"(",
"testing",
"is",
"not",
"part",
"of",
"the",
"protocol",
")",
"active",
"hepatic",
"disease",
"(",
"i.e.",
",",
"Hepatitis",
"B",
"or",
"C",
")",
"due",
"to",
"risk",
"of",
"drug",
"interactions",
"with",
"anti-viral",
"therapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02584309
|
10:37:cancer,,72:103:cancer,120:135:cancer,140:150:cancer,154:189:cancer,214:229:treatment
|
Prior or second primary malignancies within the last two years (except carcinoma in situ of the cervix, non-metastatic prostate cancer, or basal cell or squamous cell carcinoma of the skin which were treated with local resection only
| 1
|
[
"Prior",
"or",
"second",
"primary",
"malignancies",
"within",
"the",
"last",
"two",
"years",
"(",
"except",
"carcinoma",
"in",
"situ",
"of",
"the",
"cervix",
",",
"non-metastatic",
"prostate",
"cancer",
",",
"or",
"basal",
"cell",
"or",
"squamous",
"cell",
"carcinoma",
"of",
"the",
"skin",
"which",
"were",
"treated",
"with",
"local",
"resection",
"only"
] |
[
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
3,
3,
3,
0,
0,
3,
3,
0,
0,
3,
3,
0,
3,
3,
3,
3,
3,
3,
0,
0,
0,
0,
1,
1,
0
] |
NCT01990209
|
1:16:cancer,,,
|
Triple negative (ER-/PR-/HER2-)
| 1
|
[
"Triple",
"negative",
"(",
"ER-/PR-/HER2-",
")"
] |
[
3,
3,
0,
0,
0
] |
NCT03058029
|
19:37:treatment,39:57:treatment,59:69:treatment,73:83:treatment
|
Administration of Prototype 2 (GSP2), Prototype 3 (GSP3), Gelesis100,or Gelesis200 in a previous study
| 1
|
[
"Administration",
"of",
"Prototype",
"2",
"(",
"GSP2",
")",
",",
"Prototype",
"3",
"(",
"GSP3",
")",
",",
"Gelesis100",
",",
"or",
"Gelesis200",
"in",
"a",
"previous",
"study"
] |
[
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
1,
0,
0,
0,
0
] |
NCT02309580
|
1:19:treatment,21:37:treatment,43:50:treatment,,105:114:treatment
|
Previous radiation, hormonal therapy, and surgery must have been discontinued at least 2 weeks prior to treatment in this study and adverse effects must have resolved
| 1
|
[
"Previous",
"radiation",
",",
"hormonal",
"therapy",
",",
"and",
"surgery",
"must",
"have",
"been",
"discontinued",
"at",
"least",
"2",
"weeks",
"prior",
"to",
"treatment",
"in",
"this",
"study",
"and",
"adverse",
"effects",
"must",
"have",
"resolved"
] |
[
1,
1,
0,
1,
1,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01754779
|
,,26:36:treatment
|
>300mg/d in men prior to indapamide use
| 1
|
[
">",
"300mg/d",
"in",
"men",
"prior",
"to",
"indapamide",
"use"
] |
[
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT03116464
|
81:89:chronic_disease
|
Be the primary unpaid family or friend who helps or supports an individual with dementia
| 1
|
[
"Be",
"the",
"primary",
"unpaid",
"family",
"or",
"friend",
"who",
"helps",
"or",
"supports",
"an",
"individual",
"with",
"dementia"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2
] |
NCT02452268
|
34:72:treatment,
|
autoimmune event associated with prior ipilimumab (anti-CTLA-4) therapy that has been completely resolved for more than 4 weeks prior to C1D1
| 1
|
[
"autoimmune",
"event",
"associated",
"with",
"prior",
"ipilimumab",
"(",
"anti-CTLA-4",
")",
"therapy",
"that",
"has",
"been",
"completely",
"resolved",
"for",
"more",
"than",
"4",
"weeks",
"prior",
"to",
"C1D1"
] |
[
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02311361
|
1:4:chronic_disease,33:56:treatment,149:175:treatment,180:204:treatment
|
HIV-positive patients receiving anti-retroviral therapy are excluded from this study due to the possibility of pharmacokinetic interactions between antiretroviral medications and Tremelimumab or MEDI4736
| 1
|
[
"HIV-positive",
"patients",
"receiving",
"anti-retroviral",
"therapy",
"are",
"excluded",
"from",
"this",
"study",
"due",
"to",
"the",
"possibility",
"of",
"pharmacokinetic",
"interactions",
"between",
"antiretroviral",
"medications",
"and",
"Tremelimumab",
"or",
"MEDI4736"
] |
[
2,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
1,
1
] |
NCT01954966
|
1:9:chronic_disease
|
diabetes
| 1
|
[
"diabetes"
] |
[
2
] |
NCT02498951
|
47:52:cancer,56:91:cancer,95:126:cancer
|
Patients with a history of curatively treated basal or squamous cell carcinoma of the skin or in situ carcinoma of the cervix
| 1
|
[
"Patients",
"with",
"a",
"history",
"of",
"curatively",
"treated",
"basal",
"or",
"squamous",
"cell",
"carcinoma",
"of",
"the",
"skin",
"or",
"in",
"situ",
"carcinoma",
"of",
"the",
"cervix"
] |
[
0,
0,
0,
0,
0,
0,
0,
3,
0,
3,
3,
3,
3,
3,
3,
0,
3,
3,
3,
3,
3,
3
] |
NCT02332850
|
,75:84:treatment
|
The following laboratory results must be met within 7 days of study drug (treatment) administration
| 1
|
[
"The",
"following",
"laboratory",
"results",
"must",
"be",
"met",
"within",
"7",
"days",
"of",
"study",
"drug",
"(",
"treatment",
")",
"administration"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0
] |
NCT02166905
|
7:24:chronic_disease,32:50:chronic_disease,61:72:treatment,74:92:chronic_disease
|
Other serious illnesses (e.g., serious infections requiring antibiotics, bleeding disorders)
| 1
|
[
"Other",
"serious",
"illnesses",
"(",
"e.g.",
",",
"serious",
"infections",
"requiring",
"antibiotics",
",",
"bleeding",
"disorders",
")"
] |
[
0,
2,
2,
0,
0,
0,
0,
0,
0,
1,
0,
2,
2,
0
] |
NCT02408861
|
56:68:chronic_disease
|
Participants with clinical or radiographic evidence of pancreatitis
| 1
|
[
"Participants",
"with",
"clinical",
"or",
"radiographic",
"evidence",
"of",
"pancreatitis"
] |
[
0,
0,
0,
0,
0,
0,
0,
2
] |
NCT02462161
|
13:21:chronic_disease
|
Preexisting diabetes
| 1
|
[
"Preexisting",
"diabetes"
] |
[
0,
2
] |
NCT02544880
|
1:16:treatment,25:37:treatment
|
Prior radiation and any chemotherapy
| 1
|
[
"Prior",
"radiation",
"and",
"any",
"chemotherapy"
] |
[
1,
1,
0,
0,
1
] |
NCT02355535
|
18:49:treatment,119:133:chronic_disease,135:159:chronic_disease,161:184:chronic_disease,,,
|
Abnormalities on 12-lead electrocardiogram (ECG) considered by the investigator to be clinically significant (such as acute ischemia, left bundle branch block, ventricular arrhythmias) or baseline prolongation of the rate-corrected QT interval (e.g., repeated demonstration of QTc interval > 480 milliseconds)
| 1
|
[
"Abnormalities",
"on",
"12-lead",
"electrocardiogram",
"(",
"ECG",
")",
"considered",
"by",
"the",
"investigator",
"to",
"be",
"clinically",
"significant",
"(",
"such",
"as",
"acute",
"ischemia",
",",
"left",
"bundle",
"branch",
"block",
",",
"ventricular",
"arrhythmias",
")",
"or",
"baseline",
"prolongation",
"of",
"the",
"rate-corrected",
"QT",
"interval",
"(",
"e.g.",
",",
"repeated",
"demonstration",
"of",
"QTc",
"interval",
">",
"480",
"milliseconds",
")"
] |
[
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02656550
|
17:33:chronic_disease
|
Subject with an active infection
| 1
|
[
"Subject",
"with",
"an",
"active",
"infection"
] |
[
0,
0,
0,
2,
2
] |
NCT01880567
|
1:24:cancer,,
|
Relapsed/refractory MCL: Serum bilirubin < 1.5 mg/dl
| 1
|
[
"Relapsed/refractory",
"MCL",
":",
"Serum",
"bilirubin",
"<",
"1.5",
"mg/dl"
] |
[
3,
3,
0,
0,
0,
0,
0,
0
] |
NCT03148795
|
24:46:chronic_disease
|
Clinically significant cardiovascular disease
| 1
|
[
"Clinically",
"significant",
"cardiovascular",
"disease"
] |
[
0,
0,
2,
2
] |
NCT01553071
|
7:30:chronic_disease,79:98:chronic_disease,99:116:chronic_disease
|
other major medical illnesses of the cardiovascular or respiratory systems or psychiatric illness/social situations that would limit compliance with study requirements
| 1
|
[
"other",
"major",
"medical",
"illnesses",
"of",
"the",
"cardiovascular",
"or",
"respiratory",
"systems",
"or",
"psychiatric",
"illness/social",
"situations",
"that",
"would",
"limit",
"compliance",
"with",
"study",
"requirements"
] |
[
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02233868
|
12:32:chronic_disease
|
History of coagulation disorder (clinical laboratory results, medical history)
| 1
|
[
"History",
"of",
"coagulation",
"disorder",
"(",
"clinical",
"laboratory",
"results",
",",
"medical",
"history",
")"
] |
[
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03109041
|
13:23:cancer
|
Patient has metastatic disease
| 1
|
[
"Patient",
"has",
"metastatic",
"disease"
] |
[
0,
0,
3,
0
] |
NCT02485418
|
8:28:treatment,,47:55:treatment,67:74:treatment,76:91:treatment,93:105:treatment
|
Use of sedative medications within 6 hours of infusion, including opioids, benzodiazepines, barbiturates
| 1
|
[
"Use",
"of",
"sedative",
"medications",
"within",
"6",
"hours",
"of",
"infusion",
",",
"including",
"opioids",
",",
"benzodiazepines",
",",
"barbiturates"
] |
[
0,
0,
1,
1,
0,
0,
0,
0,
1,
0,
0,
1,
0,
1,
0,
1
] |
NCT01604512
|
28:43:chronic_disease,89:112:treatment,152:169:cancer,174:190:chronic_disease
|
New or increased enhancing brain lesion(s) OR nonenhancing brain lesion(s) if receiving anti-angiogenic therapy, which is considered indeterminate for tumor progression vs. radiation injury by the neuroradiologist or clinician
| 1
|
[
"New",
"or",
"increased",
"enhancing",
"brain",
"lesion",
"(",
"s",
")",
"OR",
"nonenhancing",
"brain",
"lesion",
"(",
"s",
")",
"if",
"receiving",
"anti-angiogenic",
"therapy",
",",
"which",
"is",
"considered",
"indeterminate",
"for",
"tumor",
"progression",
"vs.",
"radiation",
"injury",
"by",
"the",
"neuroradiologist",
"or",
"clinician"
] |
[
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
3,
3,
0,
2,
2,
0,
0,
0,
0,
0
] |
NCT02575404
|
,,,132:141:treatment
|
Women of childbearing potential must have a serum or urine pregnancy test performed within 72 hours prior to the start of protocol treatment
| 1
|
[
"Women",
"of",
"childbearing",
"potential",
"must",
"have",
"a",
"serum",
"or",
"urine",
"pregnancy",
"test",
"performed",
"within",
"72",
"hours",
"prior",
"to",
"the",
"start",
"of",
"protocol",
"treatment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT03170375
|
1:42:chronic_disease
|
moderate or severe valvular heart disease
| 1
|
[
"moderate",
"or",
"severe",
"valvular",
"heart",
"disease"
] |
[
2,
2,
2,
2,
2,
2
] |
NCT02560766
|
,,,,,,,,308:317:treatment,
|
Sexually active patients must agree to use 2 medically accepted methods of contraception, 1 of which is a highly effective method (e.g., hormonal or intrauterine device [IUD]) [the second may be a barrier method (e.g., male condom, female condom, diaphragm or cervical cap)], during the course of the study treatment and for 4 weeks after the last dose of study treatment
| 1
|
[
"Sexually",
"active",
"patients",
"must",
"agree",
"to",
"use",
"2",
"medically",
"accepted",
"methods",
"of",
"contraception",
",",
"1",
"of",
"which",
"is",
"a",
"highly",
"effective",
"method",
"(",
"e.g.",
",",
"hormonal",
"or",
"intrauterine",
"device",
"[",
"IUD",
"]",
")",
"[",
"the",
"second",
"may",
"be",
"a",
"barrier",
"method",
"(",
"e.g.",
",",
"male",
"condom",
",",
"female",
"condom",
",",
"diaphragm",
"or",
"cervical",
"cap",
")",
"]",
",",
"during",
"the",
"course",
"of",
"the",
"study",
"treatment",
"and",
"for",
"4",
"weeks",
"after",
"the",
"last",
"dose",
"of",
"study",
"treatment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03113695
|
1:11:cancer,
|
malignancy has been in remission without treatment for 2 years prior to enrollment
| 1
|
[
"malignancy",
"has",
"been",
"in",
"remission",
"without",
"treatment",
"for",
"2",
"years",
"prior",
"to",
"enrollment"
] |
[
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02145351
|
13:44:chronic_disease
|
Non-group 2 pulmonary arterial hypertension
| 1
|
[
"Non-group",
"2",
"pulmonary",
"arterial",
"hypertension"
] |
[
0,
0,
2,
2,
2
] |
NCT03135171
|
1:38:chronic_disease
|
Primary or secondary immunodeficiency (history of or currently active) unless related to primary disease under investigation
| 1
|
[
"Primary",
"or",
"secondary",
"immunodeficiency",
"(",
"history",
"of",
"or",
"currently",
"active",
")",
"unless",
"related",
"to",
"primary",
"disease",
"under",
"investigation"
] |
[
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02152956
|
1:20:treatment
|
ophthalmic solution
| 1
|
[
"ophthalmic",
"solution"
] |
[
1,
1
] |
NCT02487095
|
33:45:treatment,60:73:treatment,,93:105:treatment,
|
Subjects must not have received chemotherapy, or undergone major surgery within 4 weeks and radiotherapy within 24 hours prior to enrollment
| 1
|
[
"Subjects",
"must",
"not",
"have",
"received",
"chemotherapy",
",",
"or",
"undergone",
"major",
"surgery",
"within",
"4",
"weeks",
"and",
"radiotherapy",
"within",
"24",
"hours",
"prior",
"to",
"enrollment"
] |
[
0,
0,
0,
0,
0,
1,
0,
0,
0,
1,
1,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT00673842
|
1:27:treatment,35:59:chronic_disease,68:74:chronic_disease
|
mechanical tricuspid valve, known vascular access problems, active sepsis, etc
| 1
|
[
"mechanical",
"tricuspid",
"valve",
",",
"known",
"vascular",
"access",
"problems",
",",
"active",
"sepsis",
",",
"etc"
] |
[
1,
1,
1,
0,
0,
2,
2,
2,
0,
0,
2,
0,
0
] |
NCT02573883
|
1:31:treatment,33:43:treatment,45:57:treatment
|
topical calcineurin inhibitors (tacrolimus, pimecrolimus)
| 1
|
[
"topical",
"calcineurin",
"inhibitors",
"(",
"tacrolimus",
",",
"pimecrolimus",
")"
] |
[
1,
1,
1,
0,
1,
0,
1,
0
] |
NCT02446457
|
17:42:chronic_disease,46:52:chronic_disease,54:80:chronic_disease,95:103:treatment,107:126:chronic_disease
|
Has evidence of interstitial lung disease or active, non-infectious pneumonitis that required steroids or current pneumonitis
| 1
|
[
"Has",
"evidence",
"of",
"interstitial",
"lung",
"disease",
"or",
"active",
",",
"non-infectious",
"pneumonitis",
"that",
"required",
"steroids",
"or",
"current",
"pneumonitis"
] |
[
0,
0,
0,
2,
2,
2,
0,
2,
0,
2,
2,
0,
0,
1,
0,
2,
2
] |
NCT01059786
|
,59:68:treatment
|
agree to use an acceptable method of birth control during treatment and for twelve months after completion of treatment
| 1
|
[
"agree",
"to",
"use",
"an",
"acceptable",
"method",
"of",
"birth",
"control",
"during",
"treatment",
"and",
"for",
"twelve",
"months",
"after",
"completion",
"of",
"treatment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02121184
|
16:37:treatment
|
Use of chronic analgesic medications
| 1
|
[
"Use",
"of",
"chronic",
"analgesic",
"medications"
] |
[
0,
0,
0,
1,
1
] |
NCT01415752
|
15:19:chronic_disease
|
No history of AIDS-defining conditions
| 1
|
[
"No",
"history",
"of",
"AIDS-defining",
"conditions"
] |
[
0,
0,
0,
2,
0
] |
NCT03181126
|
17:27:treatment
|
Participants on venetoclax at screening may enroll and remain on venetoclax
| 1
|
[
"Participants",
"on",
"venetoclax",
"at",
"screening",
"may",
"enroll",
"and",
"remain",
"on",
"venetoclax"
] |
[
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02573376
|
1:4:chronic_disease,,,
|
HCV genotype 1, 4, 5, 6
| 1
|
[
"HCV",
"genotype",
"1",
",",
"4",
",",
"5",
",",
"6"
] |
[
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02365467
|
44:72:treatment
|
Subject must be considered a candidate for revascularization of the LSA
| 1
|
[
"Subject",
"must",
"be",
"considered",
"a",
"candidate",
"for",
"revascularization",
"of",
"the",
"LSA"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1
] |
NCT02266329
|
12:15:chronic_disease
|
History of TBI more severe than that classified as mild by DVBIC criteria
| 1
|
[
"History",
"of",
"TBI",
"more",
"severe",
"than",
"that",
"classified",
"as",
"mild",
"by",
"DVBIC",
"criteria"
] |
[
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02799095
|
59:72:allergy_name
|
Subjects with known hypersensitivity to any components of pembrolizumab (for patients in combination arm only)
| 1
|
[
"Subjects",
"with",
"known",
"hypersensitivity",
"to",
"any",
"components",
"of",
"pembrolizumab",
"(",
"for",
"patients",
"in",
"combination",
"arm",
"only",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
4,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02217709
|
50:67:treatment
|
Patients should not be considered candidates for radiation therapy
| 1
|
[
"Patients",
"should",
"not",
"be",
"considered",
"candidates",
"for",
"radiation",
"therapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT03125902
|
16:39:treatment,
|
Treatment with investigational therapy within 30 days prior to initiation of study treatment
| 1
|
[
"Treatment",
"with",
"investigational",
"therapy",
"within",
"30",
"days",
"prior",
"to",
"initiation",
"of",
"study",
"treatment"
] |
[
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01554410
|
41:64:cancer
|
Histologically-proven, invasive primary carcinoma of the cervix
| 1
|
[
"Histologically-proven",
",",
"invasive",
"primary",
"carcinoma",
"of",
"the",
"cervix"
] |
[
0,
0,
0,
0,
3,
3,
3,
3
] |
NCT02576301
|
13:37:chronic_disease
|
Symptomatic congestive heart failure
| 1
|
[
"Symptomatic",
"congestive",
"heart",
"failure"
] |
[
0,
2,
2,
2
] |
NCT00720785
|
52:63:cancer
|
Diagnosed with histologically confirmed metastatic solid tumor
| 1
|
[
"Diagnosed",
"with",
"histologically",
"confirmed",
"metastatic",
"solid",
"tumor"
] |
[
0,
0,
0,
0,
0,
3,
3
] |
NCT03010137
|
73:82:allergy_name,99:113:treatment,133:154:treatment
|
All patients who previously demonstrated a hypersensitivity reaction to adhesives and qualify for panniculectomy in preparation for renal transplantation, or all patients who are undergoing panniculectomy for reasons other than in preparation for renal transplantation (i.e. after massive weight loss or for cosmetic reasons)
| 1
|
[
"All",
"patients",
"who",
"previously",
"demonstrated",
"a",
"hypersensitivity",
"reaction",
"to",
"adhesives",
"and",
"qualify",
"for",
"panniculectomy",
"in",
"preparation",
"for",
"renal",
"transplantation",
",",
"or",
"all",
"patients",
"who",
"are",
"undergoing",
"panniculectomy",
"for",
"reasons",
"other",
"than",
"in",
"preparation",
"for",
"renal",
"transplantation",
"(",
"i.e",
".",
"after",
"massive",
"weight",
"loss",
"or",
"for",
"cosmetic",
"reasons",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
4,
0,
0,
0,
1,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00412594
|
14:17:cancer
|
Diagnosis of HCL established by bone marrow examination
| 1
|
[
"Diagnosis",
"of",
"HCL",
"established",
"by",
"bone",
"marrow",
"examination"
] |
[
0,
0,
3,
0,
0,
0,
0,
0
] |
NCT02484404
|
27:47:cancer,100:109:treatment,113:143:treatment
|
Patients who have a known KRAS wild type tumor must have progressed, been intolerant of or refused cetuximab or panitumumab-based chemotherapy
| 1
|
[
"Patients",
"who",
"have",
"a",
"known",
"KRAS",
"wild",
"type",
"tumor",
"must",
"have",
"progressed",
",",
"been",
"intolerant",
"of",
"or",
"refused",
"cetuximab",
"or",
"panitumumab-based",
"chemotherapy"
] |
[
0,
0,
0,
0,
0,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.